News

Sanofi India announced the appointment of Debajit Roy as Sales & Customer Engagement Head - Diabetes, designated as Senior Management Personnel of the Company with effect from 8 June 2026.

Net profit of Sanofi India declined 14.14% to Rs 102.60 crore in the quarter ended March 2026 as against Rs 119.50 crore during the previous quarter ended March 2025. Sales declined 11.87% to Rs 472.30 crore in the quarter ended March 2026 as against Rs 535.90 crore during the previous quarter ended March 2025. ParticularsQuarter EndedMar. 2026Mar. 2025% Var. Sales472.30535.90 -12 OPM %30.2432.08 - PBDT146.90174.90 -16 PBT137.90165.30 -17 NP102.60119.50 -14 Powered by Capital Market - Live News

Sanofi India will hold a meeting of the Board of Directors of the Company on 28 April 2026.

Sanofi India announced that the 70th Annual General Meeting(AGM) of the company will be held on 29 April 2026.Powered by Capital Market - Live News

Sanofi India announced that the Board of Directors of the Company at its meeting held on 25 February 2026, inter alia, have recommended the final dividend of Rs 48 per equity Share (i.e. 480%) , subject to the approval of the shareholders.Powered by Capital Market - Live News